Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 901

1.

A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed.

Norberg M, Eriksson JW, Lindahl B, Andersson C, Rolandsson O, Stenlund H, Weinehall L.

J Intern Med. 2006 Sep;260(3):263-71. Erratum in: J Intern Med. 2006 Nov;260(5):491.

2.

Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects.

Ko GT, Chan JC, Yeung VT, Chow CC, Tsang LW, Li JK, So WY, Wai HP, Cockram CS.

Diabetes Care. 1998 Aug;21(8):1221-5.

PMID:
9702423
3.

HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP).

Perry RC, Shankar RR, Fineberg N, McGill J, Baron AD; Early Diabetes Intervention Program (EDIP).

Diabetes Care. 2001 Mar;24(3):465-71.

PMID:
11289469
4.

Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.

Hu Y, Liu W, Chen Y, Zhang M, Wang L, Zhou H, Wu P, Teng X, Dong Y, Zhou Jw, Xu H, Zheng J, Li S, Tao T, Hu Y, Jia Y.

Acta Diabetol. 2010 Sep;47(3):231-6. doi: 10.1007/s00592-009-0143-2. Epub 2009 Sep 17.

PMID:
19760291
5.
6.

Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation.

Valderhaug TG, Jenssen T, Hartmann A, Midtvedt K, Holdaas H, Reisaeter AV, Hjelmesaeth J.

Transplantation. 2009 Aug 15;88(3):429-34. doi: 10.1097/TP.0b013e3181af1f53.

PMID:
19667949
7.

Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects.

Ko GT, Chan JC, Tsang LW, Cockram CS.

Diabetes Care. 2000 Dec;23(12):1770-3.

9.

A two-step strategy for identification of high-risk subjects for a clinical trial of prevention of NIDDM.

Narayan KM, Hanson RL, Pettitt DJ, Bennett PH, Knowler WC.

Diabetes Care. 1996 Sep;19(9):972-8.

PMID:
8875091
10.

Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance.

Mannucci E, Ognibene A, Sposato I, Brogi M, Gallori G, Bardini G, Cremasco F, Messeri G, Rotella CM.

Acta Diabetol. 2003 Dec;40(4):181-6.

PMID:
14740278
11.

The combination of fasting plasma glucose and glycosylated hemoglobin predicts type 2 diabetes in Japanese workers.

Inoue K, Matsumoto M, Kobayashi Y.

Diabetes Res Clin Pract. 2007 Sep;77(3):451-8. Epub 2007 Mar 7.

PMID:
17346846
12.
13.
14.

Fasting plasma glucose in screening for NIDDM in the U.S. and Israel.

Modan M, Harris MI.

Diabetes Care. 1994 May;17(5):436-9.

PMID:
7741837
15.

A large proportion of prediabetes and diabetes goes undiagnosed when only fasting plasma glucose and/or HbA1c are measured in overweight or obese patients.

Cosson E, Hamo-Tchatchouang E, Banu I, Nguyen MT, Chiheb S, Ba H, Valensi P.

Diabetes Metab. 2010 Sep;36(4):312-8. doi: 10.1016/j.diabet.2010.02.004.

PMID:
20627649
16.

Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin a1c values.

Woerle HJ, Pimenta WP, Meyer C, Gosmanov NR, Szoke E, Szombathy T, Mitrakou A, Gerich JE.

Arch Intern Med. 2004 Aug 9-23;164(15):1627-32.

PMID:
15302632
17.

Noninvasive type 2 diabetes screening: superior sensitivity to fasting plasma glucose and A1C.

Maynard JD, Rohrscheib M, Way JF, Nguyen CM, Ediger MN.

Diabetes Care. 2007 May;30(5):1120-4. Epub 2007 Mar 2.

PMID:
17337498
18.
19.

Fasting plasma glucose and HbA1c as risk factors for Type 2 diabetes.

Inoue K, Matsumoto M, Akimoto K.

Diabet Med. 2008 Oct;25(10):1157-63. doi: 10.1111/j.1464-5491.2008.02572.x.

PMID:
19046193

Supplemental Content

Support Center